Reward Sensitivity and Pharmacotherapy for Smoking Cessation
Reward Sensitivity and Pharmacotherapy for Smoking Cessation
Active, not recruiting · NCT02162849 · Registry updated 2026-07-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Reward Sensitivity and Pharmacotherapy for Smoking Cessation | Tobacco Use Cessation | Active, not recruiting | Phase 4 | 2026-07-16 | NCT02162849 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| M.D. Anderson Cancer Center | 1145 |
| NAL PHARMA | 1 |
| Pfizer | 431 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Texas MD Anderson Cancer Center | Houston | United States | 192 |